ClinConnect ClinConnect Logo
Search / Trial NCT06289439

Effect of Green Tea Supplementation in Older Adult Women

Launched by UNIVERSITY OF VALLADOLID · Feb 25, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Sarcopenia Green Tea Exercise Quality Of Life Physical Performance Health Biomarkers

ClinConnect Summary

This clinical trial is studying how green tea supplements might help improve physical performance and quality of life in older women with decreased strength and endurance as they age. Specifically, the researchers are giving participants aged 60 to 80 years old a daily dose of green tea extract for 10 weeks to see if it enhances their grip strength, walking speed, and overall fitness, while also looking at health markers related to their wellbeing.

To be eligible for the study, women must be able to participate in a physical activity program tailored to their abilities. However, those with certain health issues, like severe heart conditions, uncontrolled blood pressure, or recent major illnesses, will not be included in the trial. Participants can expect to undergo physical tests and complete a quality of life questionnaire both at the start and at the end of the 10-week period. This study aims to gather valuable information that could help improve the health and daily lives of older women.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Older adult women between 60 and 80 years old, with the ability to carry out a physical activity program adapted to their age and health condition.
  • Exclusion Criteria:
  • 1. Functional limitation using the Barthel scale (less than 100 = maximum score) and the Lawton-Brody scale (less than 8 = maximum value).
  • 2. Acute/chronic heart failure with NYHA (New York Heart Association) scale \>II.
  • 3. Uncontrolled hypertension (\>180/100 mm Hg).
  • 4. Uncontrolled orthostatic hypotension.
  • 5. Uncontrolled atrial or ventricular arrhythmias, aortic dissecting aneurysm, severe aortic stenosis, acute endocarditis/pericarditis.
  • 6. Recent acute myocardial infarction (3 to 6 months) or unstable angina.
  • 7. Acute thromboembolic disease.
  • 8. Acute/chronic respiratory failure.
  • 9. Moderate/severe chronic obstructive pulmonary disease (COPD) with Bodex index C or D.
  • 10. Diabetes mellitus with acute decompensation or uncontrolled hypoglycemia.
  • 11. Recent bone fracture (last month).
  • 12. History of dementia (suspected by the MAP environment and diagnosed).
  • 13. Previous supplementation with amino acids or other nutritional compounds to improve physical performance.
  • 14. Any other circumstance that your doctor considers prevents physical activity.

About University Of Valladolid

The University of Valladolid, a prestigious academic institution in Spain, is dedicated to advancing medical research and improving healthcare outcomes through rigorous clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of researchers, healthcare professionals, and state-of-the-art facilities to conduct innovative studies across various medical fields. Committed to ethical standards and patient safety, the University of Valladolid aims to contribute valuable insights to the scientific community and enhance clinical practices through evidence-based findings.

Locations

Soria, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported